Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 0 | 0 | 0 | 0 |
| Cost of revenue | 0 | 0 | 0 | 0 |
| Gross profit | 0 | 0 | 0 | 0 |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 4M | 4M | 3M | 2M |
| Other operating expenses | — | — | — | — |
| Operating income | -4M | -4M | -3M | -2M |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 7M | 7M | 8M | 7M |
| Other income expense | -11M | -127M | 31M | 179M |
| Pretax income | -22M | -138M | 20M | 170M |
| Tax provision | -5M | -29M | 5M | 36M |
| Net income | -17M | -109M | 15M | 134M |
| Basic EPS | -0.2 | — | 0.2 | 1.5 |
| Diluted EPS | -0.2 | — | 0.2 | 1.5 |
| Basic average shares | 91.8M | — | 91.7M | 92M |
| Diluted average shares | 91.8M | — | 91.7M | 92M |
| EBITDA | 88M | 57M | 122M | 89M |
| Net income from continuing op. | 77M | -109M | 15M | 134M |
| Minority interests | 0 | 2M | 0 | 0 |
| Preferred stock dividends | — | — | — | — |